PHN-012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PHN-012, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PHN-012 in Patients With Advanced Solid Tumors [Phase 1]